NanoPowers Frequently Asked Questions (FAQ)
What is NanoPowers's latest funding round?
NanoPowers's latest funding round is Series A.
How much did NanoPowers raise?
NanoPowers raised a total of $4.5M.
Who are the investors of NanoPowers?
Investors of NanoPowers include Novartis Venture Funds.
Who are NanoPowers's competitors?
Competitors of NanoPowers include MicroTransponder, ConforMIS, Acelity, Entellus Medical, TriVascular and 7 more.
Compare NanoPowers to Competitors
EastMed is a Halifax based company incorporated to develop, manufacture and market medical devices. It is currently developing a new self-fitting incontinence pessary for women. Per the company, a Canadian Patent has been secured and a US patent is pending.
Bio Control Medical offers implantable devices for the treatment of incontinence and congestive heart failure.
Neotonus is a medical device company which utilizes a non-invasive technology known as Extracorporeal Magnetic Innervation, or ExMI, initially targeted at urinary incontinence.
OrthAlign is a company that specializes in the development of advanced technology for joint surgery, operating within the healthcare and technology sectors. The company's primary offerings include user-friendly, cost-effective technology that aids orthopedic surgeons in achieving precise alignment during hip and knee replacement surgeries. OrthAlign's solutions are primarily utilized within the healthcare industry. It was founded in 2008 and is based in Aliso Viejo, California.
Freedom Innovations is a high technology provider of premium prosthetic devices, a growing segment of the non-invasive orthopedic market. It deals with making prosthetic devices with latest technological developments and customization for lower limb amputations. The branded carbon fiber foot products lead the industry in reputation and growth rate. The company's first microprocessor-controlled product, the Pli' MPC Knee, was introduced in May 2007, serving as an entry into the SMART technology arena.What aims to make the company and the products is the high customization in the prosthetic devices market ranging from different limbs for swimmers to bikers to soldiers and so on. In February 2012, Health Evolution Partners acquired a majority stake in Freedom Innovations. The valuation of Freedom Innovations was undisclosed. Other terms of the deal were not released.
Endologix is a company focused on the development and manufacturing of minimally invasive treatments for aortic disorders, operating within the medical devices industry. The company's main offerings include a variety of endovascular stent grafts, which are used for the treatment of abdominal aortic aneurysms (AAA), a condition characterized by a weakening of the wall of the aorta that can lead to a balloon-like enlargement. Endologix primarily serves the healthcare sector, particularly in areas related to vascular disease and aortic disorders. It was founded in 1992 and is based in Irvine, California.